These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37517581)

  • 41. Paeoniflorin Ameliorates Chronic Hypoxia/SU5416-Induced Pulmonary Arterial Hypertension by Inhibiting Endothelial-to-Mesenchymal Transition.
    Yu M; Peng L; Liu P; Yang M; Zhou H; Ding Y; Wang J; Huang W; Tan Q; Wang Y; Xie W; Kong H; Wang H
    Drug Des Devel Ther; 2020; 14():1191-1202. PubMed ID: 32256050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular vesicles derived from hypoxia-preconditioned bone marrow mesenchymal stem cells ameliorate lower limb ischemia by delivering miR-34c.
    Peng X; Liu J; Ren L; Liang B; Wang H; Hou J; Yuan Q
    Mol Cell Biochem; 2023 Jul; 478(7):1645-1658. PubMed ID: 36729282
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Silibinin efficacy in a rat model of pulmonary arterial hypertension using monocrotaline and chronic hypoxia.
    Zhang T; Kawaguchi N; Yoshihara K; Hayama E; Furutani Y; Kawaguchi K; Tanaka T; Nakanishi T
    Respir Res; 2019 Apr; 20(1):79. PubMed ID: 31023308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-based engineering of mesenchymal stem cell extracellular vesicles for treatment of retinal ischemic disorders: Engineered extracellular vesiclesand retinal ischemia.
    Mathew B; Acha LG; Torres LA; Huang CC; Liu A; Kalinin S; Leung K; Dai Y; Feinstein DL; Ravindran S; Roth S
    Acta Biomater; 2023 Mar; 158():782-797. PubMed ID: 36638942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
    Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
    J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mesenchymal Stromal Cells From Emphysematous Donors and Their Extracellular Vesicles Are Unable to Reverse Cardiorespiratory Dysfunction in Experimental Severe Emphysema.
    Antunes MA; Braga CL; Oliveira TB; Kitoko JZ; Castro LL; Xisto DG; Coelho MS; Rocha N; Silva-Aguiar RP; Caruso-Neves C; Martins EG; Carvalho CF; Galina A; Weiss DJ; Lapa E Silva JR; Lopes-Pacheco M; Cruz FF; Rocco PRM
    Front Cell Dev Biol; 2021; 9():661385. PubMed ID: 34136481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension.
    Liang OD; Mitsialis SA; Chang MS; Vergadi E; Lee C; Aslam M; Fernandez-Gonzalez A; Liu X; Baveja R; Kourembanas S
    Stem Cells; 2011 Jan; 29(1):99-107. PubMed ID: 20957739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells.
    Kang IS; Suh J; Lee MN; Lee C; Jin J; Lee C; Yang YI; Jang Y; Oh GT
    BMB Rep; 2020 Feb; 53(2):118-123. PubMed ID: 31964470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury.
    Mardpour S; Hassani SN; Mardpour S; Sayahpour F; Vosough M; Ai J; Aghdami N; Hamidieh AA; Baharvand H
    J Cell Physiol; 2018 Dec; 233(12):9330-9344. PubMed ID: 29266258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal Stromal Cell-derived Exosomes Attenuate Experimental Pulmonary Arterial Hypertension.
    Ge L; Jiang W; Zhang S; Wang J; Xin Q; Sun C; Li K; Qi T; Luan Y
    Curr Pharm Biotechnol; 2021; 22(12):1654-1662. PubMed ID: 33390109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drag-reducing polymers attenuates pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension.
    Wang Y; Wu F; Hu F; Wu Y; Zhou J; Xu Y; Shao X; Hu T
    Clin Hemorheol Microcirc; 2020; 74(2):189-200. PubMed ID: 31476149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.
    Fukumitsu M; Suzuki K
    J Cardiol; 2019 Oct; 74(4):304-312. PubMed ID: 31109735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo.
    Harper RL; Maiolo S; Ward RJ; Seyfang J; Cockshell MP; Bonder CS; Reynolds PN
    Respirology; 2019 Nov; 24(11):1095-1103. PubMed ID: 30977250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling.
    Zhang S; Liu X; Ge LL; Li K; Sun Y; Wang F; Han Y; Sun C; Wang J; Jiang W; Xin Q; Xu C; Chen Y; Chen O; Zhang Z; Luan Y
    Respir Res; 2020 Mar; 21(1):71. PubMed ID: 32192495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracellular vesicles derived from hypoxia-preconditioned olfactory mucosa mesenchymal stem cells enhance angiogenesis via miR-612.
    Ge L; Xun C; Li W; Jin S; Liu Z; Zhuo Y; Duan D; Hu Z; Chen P; Lu M
    J Nanobiotechnology; 2021 Nov; 19(1):380. PubMed ID: 34802444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension.
    Oh S; Jang AY; Chae S; Choi S; Moon J; Kim M; Spiekerkoetter E; Zamanian RT; Yang PC; Hwang D; Byun K; Chung WJ
    Sci Rep; 2021 Jan; 11(1):2012. PubMed ID: 33479312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury.
    Mao C; Li D; Zhou E; Gao E; Zhang T; Sun S; Gao L; Fan Y; Wang C
    Aging (Albany NY); 2021 Feb; 13(4):6156-6170. PubMed ID: 33578393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.
    Ren W; Hou J; Yang C; Wang H; Wu S; Wu Y; Zhao X; Lu C
    J Exp Clin Cancer Res; 2019 Feb; 38(1):62. PubMed ID: 30736829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of vascular endothelial integrity by mesenchymal stem cell extracellular vesicles after hemorrhagic shock and trauma.
    Barry M; Trivedi A; Miyazawa B; Vivona LR; Shimmin D; Pathipati P; Keane C; Cuschieri J; Pati S
    J Transl Med; 2024 Jun; 22(1):588. PubMed ID: 38907252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.